Literature DB >> 9742062

Caldesmon inhibits active crossbridges in unstimulated vascular smooth muscle: an antisense oligodeoxynucleotide approach.

J J Earley1, X Su, R S Moreland.   

Abstract

Caldesmon is a thin-filament-associated protein believed to be important in the regulation of smooth muscle contraction, although the precise mechanism is unknown. We used antisense oligodeoxynucleotides to produce intact swine carotid smooth muscle tissue deficient in h-caldesmon. Caldesmon content was decreased by 78% after 7 days in culture with antisense oligodeoxynucleotides but was unchanged in tissues in the presence of sense oligodeoxynucleotides or vehicle. Antisense oligodeoxynucleotides produced a significant decrease in the caldesmon/actin ratio, but no change was measured in the calponin/actin ratio, suggesting that the effect was specific to caldesmon and not other thin-filament-associated proteins. Basal and KCl-stimulated levels of myosin light chain phosphorylation were not different among tissues from all 3 groups. In contrast, h-caldesmon-deficient tissues produced 62% less KCl-induced force than controls. Unstimulated h-caldesmon-deficient smooth muscle tissues stretched and then released, redeveloped force, demonstrating active crossbridge cycling; strips containing normal h-caldesmon content did not redevelop force on release. We suggest that in resting vascular smooth muscle, active crossbridges are inhibited by caldesmon. Therefore, regulation of smooth muscle includes a thin-filament-based disinhibition component.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9742062     DOI: 10.1161/01.res.83.6.661

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  19 in total

1.  Ca2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta.

Authors:  I Kim; H D Je; C Gallant; Q Zhan; D V Riper; J A Badwey; H A Singer; K G Morgan
Journal:  J Physiol       Date:  2000-07-15       Impact factor: 5.182

2.  Mutant Caldesmon lacking cdc2 phosphorylation sites delays M-phase entry and inhibits cytokinesis.

Authors:  S Yamashiro; H Chern; Y Yamakita; F Matsumura
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

3.  Smooth muscle caldesmon modulates peristalsis in the wild type and non-innervated zebrafish intestine.

Authors:  J Abrams; G Davuluri; C Seiler; M Pack
Journal:  Neurogastroenterol Motil       Date:  2012-03       Impact factor: 3.598

4.  Bladder smooth muscle organ culture preparation maintains the contractile phenotype.

Authors:  Tanchun Wang; Derek M Kendig; Shaohua Chang; Danielle M Trappanese; Samuel Chacko; Robert S Moreland
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-15

5.  Regulation of mitogen-activated protein kinase by protein kinase C and mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle.

Authors:  Danielle M Trappanese; Sarah Sivilich; Hillevi K Ets; Farah Kako; Michael V Autieri; Robert S Moreland
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-06       Impact factor: 4.249

6.  Calponin is required for agonist-induced signal transduction--evidence from an antisense approach in ferret smooth muscle.

Authors:  H D Je; S S Gangopadhyay; T D Ashworth; K G Morgan
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

7.  Ablation of smooth muscle caldesmon affects the relaxation kinetics of arterial muscle.

Authors:  Hongqiu Guo; Renjian Huang; Shingo Semba; Jolanta Kordowska; Yang Hoon Huh; Yana Khalina-Stackpole; Katsuhide Mabuchi; Toshio Kitazawa; Chih-Lueh Albert Wang
Journal:  Pflugers Arch       Date:  2012-11-14       Impact factor: 3.657

8.  Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability.

Authors:  Qifeng Jiang; Renjian Huang; Shaoxi Cai; Chih-Lueh A Wang
Journal:  J Biomed Sci       Date:  2010-02-03       Impact factor: 8.410

9.  siRNA-mediated knockdown of h-caldesmon in vascular smooth muscle.

Authors:  Elaine M Smolock; Danielle M Trappanese; Shaohua Chang; Tanchun Wang; Paul Titchenell; Robert S Moreland
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-18       Impact factor: 4.733

10.  Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta.

Authors:  Erika Shimomura; Mitsuya Shiraishi; Takahiro Iwanaga; Minoru Seto; Yasuharu Sasaki; Masahiro Ikeda; Katsuaki Ito
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.